UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 242

Sortiert nach

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Nature communications, 2017-08, Vol.8 (1), p.268-11, Article 268

2017

Volltextzugriff (PDF)

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

Leukemia, 2019-07, Vol.33 (7), p.1713-1722

2019

Volltextzugriff (PDF)

Predicting color and short-circuit current of colored BIPV modules

AIP advances, 2021-09, Vol.11 (9), p.095104-095104-12

2021

Volltextzugriff (PDF)

Stem cell origin of myelodysplastic syndromes

Oncogene, 2014-10, Vol.33 (44), p.5139-5150

2014

Volltextzugriff (PDF)

Luminescence emission from forward- and reverse-biased multicrystalline silicon solar cells

Journal of applied physics, 2009-11, Vol.106 (10), p.104510-104510-8

2009

Volltextzugriff (PDF)

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

Blood cancer journal (New York), 2017-02, Vol.7 (2), p.e535-e535

2017

Volltextzugriff (PDF)

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-07, Vol.6 (7), p.e453-e453

2016

Volltextzugriff (PDF)

Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity

Translational psychiatry, 2017-07, Vol.7 (7), p.e1167-e1167

2017

Volltextzugriff (PDF)

Glutamine and alanine-induced differential expression of intracellular IL-6, IL-8, and TNF-α in LPS-stimulated monocytes in human whole-blood

Cytokine (Philadelphia, Pa.), 2013-04, Vol.62 (1), p.52-57

2013

Volltextzugriff (PDF)

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL‐1)

HemaSphere, 2023-05, Vol.7 (S2), p.26-27

2023

Volltextzugriff (PDF)

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-09, Vol.6 (9), p.e471

2016

Volltextzugriff (PDF)

Can we cure Multiple Myeloma by 2020? Yes

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e36-e36

2015

Volltextzugriff (PDF)

FYNN—Support Program for Patients Who Have Completed Head and Neck Cancer Treatment

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1401-1401

2018

Volltextzugriff (PDF)

A Model for Multidisciplinary Care of Patients With Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1402-1403

2018

Volltextzugriff (PDF)

Pan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases

Annals of oncology, 2019-10, Vol.30, p.v762-v763

2019

Volltextzugriff (PDF)

1878PD - Pan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases

Annals of oncology, 2019-10, Vol.30, p.v762-v763

2019

Volltextzugriff (PDF)

Aberrant DNA methylation in malignant melanoma

Melanoma research, 2010-08, Vol.20 (4), p.253-265

2010

Volltextzugriff (PDF)

1878PDPan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Extending Metronomic Therapy to 28 Days (metro28) for Relapsed Refractory Multiple Myeloma (RRMM)

Blood, 2015-12, Vol.126 (23), p.5395-5395

2015

Volltextzugriff (PDF)

A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary Plasmacytoma

The American journal of case reports, 2016-03, Vol.17, p.173-176

2016

Volltextzugriff (PDF)

Re-Mineralization of Large Pelvic Lytic Lesions By CT Imaging in Patients with Multiple Myeloma: The Arkansas Experience

Blood, 2015-12, Vol.126 (23), p.4193-4193

2015

Volltextzugriff (PDF)

Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant

Hematology reports, 2017-09, Vol.9 (3), p.7094-7094

2017

Volltextzugriff (PDF)

Glutamine and alanine-induced differential expression of intracellular IL-6, IL-8, and TNF-[alpha] in LPS-stimulated monocytes in human whole-blood

Cytokine (Philadelphia, Pa.), 2013-04, Vol.62 (1), p.52-57

2013

Volltextzugriff (PDF)

PS1386 CARFILZOMIB AS PART OF A DOSE DENSE, LESS DOSE INTENSE TOTAL THERAPY APPROACH FOR HIGH RISK MYELOMA

HemaSphere, 2019-06, Vol.3 (S1), p.635-n/a

2019

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(83)
Humans
(55)
Physical Sciences
(44)
Chemistry
(39)
Physics
(39)
Chemistry, Physical
(36)
Female
(35)
Physics, Atomic, Molecular & Chemical
(32)
Animals
(31)
Male
(29)
Mice
(28)
Biological And Medical Sciences
(26)
Social Sciences
(21)
Endocrinology & Metabolism
(18)
Adolescent
(17)
Psychology
(16)
Medical Sciences
(15)
Adult
(13)
Child
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

Predicting color and short-circuit current of colored BIPV modules

Stem cell origin of myelodysplastic syndromes

Luminescence emission from forward- and reverse-biased multicrystalline silicon solar cells

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity

Glutamine and alanine-induced differential expression of intracellular IL-6, IL-8, and TNF-α in LPS-stimulated monocytes in human whole-blood

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL‐1)

P42 HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, FROM MONUMENTAL‐1

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Can we cure Multiple Myeloma by 2020? Yes

FYNN—Support Program for Patients Who Have Completed Head and Neck Cancer Treatment

A Model for Multidisciplinary Care of Patients With Head and Neck Cancer

Pan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases

1878PD - Pan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases

Aberrant DNA methylation in malignant melanoma

1878PDPan-cancer analysis of clinical acquired resistance (AR) in BRAF-driven real-world cases

Extending Metronomic Therapy to 28 Days (metro28) for Relapsed Refractory Multiple Myeloma (RRMM)

A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary Plasmacytoma

Re-Mineralization of Large Pelvic Lytic Lesions By CT Imaging in Patients with Multiple Myeloma: The Arkansas Experience

Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant

Glutamine and alanine-induced differential expression of intracellular IL-6, IL-8, and TNF-[alpha] in LPS-stimulated monocytes in human whole-blood

PS1386 CARFILZOMIB AS PART OF A DOSE DENSE, LESS DOSE INTENSE TOTAL THERAPY APPROACH FOR HIGH RISK MYELOMA

Suchergebnisse filtern